SCHEMBL4085532

SCHEMBL4085532

CCc1cc(-c2ccc(C=CC(=O)O)cc2)ccc1OC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.60
ALDH1A1 P00352 3/20 0.60
HPGD P15428 2/20 0.60
HSD17B10 Q99714 2/20 0.60
ALOX15 P16050 1/20 0.60
MAPK1 P28482 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
SNCA P37840 2/20 0.54
PKM P14618 2/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA3 P07451 1/20 0.54
CSNK2A2 P19784 1/20 0.54
CA4 P22748 1/20 0.54
CA6 P23280 1/20 0.54
CA5A P35218 1/20 0.54
CA7 P43166 1/20 0.54
CSNK2B P67870 1/20 0.54
CSNK2A1 P68400 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436579 0.88 KDM4E (0.71) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL2436577 0.88 KDM4E (0.71) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7967595 0.85 KDM4E (0.77) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7967589 0.85 KDM4E (0.77) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7970902 0.79 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7970893 0.79 KDM4E (0.66) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7966546 0.79 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7973450 0.79 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7966543 0.79 KDM4E (0.61) KDM4EALDH1A1HPGDHSD17B10ALOX15
SCHEMBL7966530 0.79 KDM4E (0.68) KDM4EALDH1A1HPGDHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090186900-A1 COMPOUND STERIX LIMITED (GB) 2009-07-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090186900-A1 COMPOUND HSD17B2, HSD17B11, CYP17A1 KDM4E 2132/4885ALDH1A1 56/4885HPGD 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.